Clinical Trials Directory

Trials / Sponsors / Annick Desjardins

Annick Desjardins

Academic / Other · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedPhase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma
Malignant Glioma
Phase 22016-02-01
TerminatedPh 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma
Malignant Glioma (WHO Grade III or IV)
Phase 12014-05-01
TerminatedPhase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure
Malignant Glioma (WHO Grade III or IV)
Phase 12013-10-01
TerminatedPanitumumab and Irinotecan for Malignant Gliomas
Malignant Glioma of Brain
Phase 22010-02-01
CompletedPharmacokinetics (PK) Study of AC480 for Recurrent Glioma
Glioma
Phase 12009-11-01
CompletedBevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)
Malignant Glioma
Phase 22009-09-01
WithdrawnPh. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma
Phase 12009-06-01
CompletedPh I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Gliosarcoma, Glioblastoma
Phase 12008-02-01
CompletedPh I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
Glioblastoma, Gliosarcoma
Phase 12007-11-01
CompletedPh I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
Glioblastoma, Gliosarcoma
Phase 12005-05-01